EUVIMEDEUVIMED entdecken
Crossref

Ginsenoside Re attenuates ferroptosis induced by hepatic ischemia-reperfusion injury via the BAP1/SLC7A11 axis

Tingfeng Yang, Shaohua Zhang, Danna Xie, Zhonghao Jiang, Liangkun Niu, RunSheng Chen, Zeyu He, Xinpeng Zhang, Hua Liu, Junjie Zhou, Xing Song, Baolin Qian und 2 weitere

International Immunopharmacology · 2026-12 · 191 · 117572

DOI: 10.1016/j.intimp.2026.117572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2026-12. Verfasst von Tingfeng Yang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery (Hepatobiliary Surgery), Department of Biliary-Pancreatic Center, The Affiliated Hospital, Southwest Medical University…. Die Arbeit nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Southwest Medical University, Sichuan Province Science and Technology Support Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatic ischemia-reperfusion injury (HIRI) is a complex clinical complication involving inflammation and multiple forms of regulated cell death, among which ferroptosis plays a critical role. Ginsenoside Re (Re) exhibits prominent antioxidant capabilities, but its exact molecular targets in HIRI are unidentified. Here, using in vivo HIRI and in vitro hypoxia/reoxygenation (H/R) models, we found that Re administration exhibited an optimal therapeutic window, significantly alleviating hepatocellular damage, inflammatory responses, and oxidative stress. Sequentially, Re suppressed ferroptosis, as characterized by reduced iron deposition, decreased lipid peroxidation, and restored expression of GPX4 and SLC7A11. Utilizing Drug Affinity Responsive Target Stability (DARTS) and 4D-DIA quantitative proteomics, we identified BRCA1-associated protein 1 (BAP1) as a direct intracellular target of Re. Re physically bound to BAP1 and down-regulated its expression, thereby relieving BAP1-mediated transcriptional suppression of SLC7A11 and bolstering glutathione synthesis. Conversely, BAP1 overexpression reversed the anti-ferroptotic and hepatoprotective effects of Re. In conclusion, our findings demonstrate that Ginsenoside Re mitigates HIRI by targeting the BAP1/SLC7A11 axis to inhibit ferroptosis, offering a promising therapeutic strategy for clinical intervention.

Schlagwörter

Stichwörter der Autor:innen

BAP1FerroptosisGinsenoside ReHepatic ischemia-reperfusion injurySLC7A11

Autor:innen und Institutionen

  • Department of General Surgery (Hepatobiliary Surgery), Department of Biliary-Pancreatic Center, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China; Metabolic Hepatobiliary and Pancreatic Diseas…
  • Department of Oncology, The Affiliated Hospital, Southwest Medical University, Luzhou, 646000, China.

Förderung

  • National Natural Science Foundation of China
  • Southwest Medical University
  • Sichuan Province Science and Technology Support Program

Zitieren

APA

Yang, T., Zhang, S., Xie, D., Jiang, Z., Niu, L., Chen, R., He, Z., Zhang, X., Liu, H., Zhou, J., Song, X., Qian, B., Ye, M., & Fu, W. (2026). Ginsenoside Re attenuates ferroptosis induced by hepatic ischemia-reperfusion injury via the BAP1/SLC7A11 axis. International Immunopharmacology, 191, 117572. https://doi.org/10.1016/j.intimp.2026.117572

Vancouver

Yang T, Zhang S, Xie D, Jiang Z, Niu L, Chen R, et al. Ginsenoside Re attenuates ferroptosis induced by hepatic ischemia-reperfusion injury via the BAP1/SLC7A11 axis. International Immunopharmacology. 2026;191:117572. doi:10.1016/j.intimp.2026.117572

BibTeX
@article{Yang2026,
  author = {Yang, Tingfeng and Zhang, Shaohua and Xie, Danna and Jiang, Zhonghao and Niu, Liangkun and Chen, RunSheng and He, Zeyu and Zhang, Xinpeng and Liu, Hua and Zhou, Junjie and Song, Xing and Qian, Baolin and Ye, Mingxing and Fu, Wenguang},
  title = {Ginsenoside Re attenuates ferroptosis induced by hepatic ischemia-reperfusion injury via the BAP1/SLC7A11 axis},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {191},
  pages = {117572},
  doi = {10.1016/j.intimp.2026.117572}
}
Kostenlos starten →